SGLT2 inhibitors may prevent atrial fibrillation, with their potential efficacy influenced by treatment duration, patient sex, and underlying atrial substrate.
Do SGLT2 inhibitors prevent atrial fibrillation?
This article discusses the role of SGLT2 inhibitors in preventing atrial fibrillation, focusing on time, sex, and substrate.
Absolute Event Rate: 0% vs 0%
Paschalis Karakasis, MD, PhD, Antonios P Antoniadis, MD, PhD, Nikolaos Fragakis, MD, PhD; Preventing Atrial Fibrillation with SGLT2 Inhibitors: Time, Sex,
Karakasis et al. (Fri,) reported a other. SGLT2 inhibitors may prevent atrial fibrillation, with their potential efficacy influenced by treatment duration, patient sex, and underlying atrial substrate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: